1. Hepatitis C Virus Treatment: The Unyielding Chasm Between Efficacy and Effectiveness 
Fasiha Kanwal, MD, MSHS, Hashem B. El-Serag, MD, MPH 
Clinical Gastroenterology and Hepatology 
Volume 12, Issue 8, Pages (August 2014)
DOI: /j.cgh
Copyright © 2014 AGA Institute Terms and Conditions

2. Figure 1
Estimated reductions in cirrhosis (A) and liver-related death (B) by 2020, assuming incremental treatment of 0% to 100% of infected persons and SVRs of 80% (adapted from Davis et al).17
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions